Participants 603 678 4
patients with bone metastases from tumors poorly responsive to chemotherapy
Participants 784 985 8
Sixty-six patients with poorly responsive tumors such as non-small cell lung cancer (NSCLC), bladder cancer, gastrointestinal cancers, kidney cancer, melanoma and metastatic carcinoma of unknown origin
Participants 1301 1321 4
66 patients enrolled
